This topic contains a solution. Click here to go to the answer

Author Question: In within-subjects designs, each participant A) is measured at least five times. B) serves as ... (Read 50 times)

ARLKQ

  • Hero Member
  • *****
  • Posts: 571
In within-subjects designs, each participant
 
  A) is measured at least five times.
  B) serves as his or her own control.
  C) is measured only once.
  D) is randomly assigned to one of two conditions.

Question 2

Which of the following is NOT a characteristic of a within-subjects design?
 
  A) Each participant is tested under each experimental condition.
  B) The scores in each condition are correlated with each other.
  C) Each participant is measured only once on the dependent variable.
  D) The critical comparison is the difference between correlated groups on the dependent variable.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

thall411

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

Answer: B

Answer to Question 2

Answer: C





 

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

For a complete list of videos, visit our video library